Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- United Therapeutics (NASDAQ: UTHR) reported weaker-than-expected third-quarter earnings. United Therapeutics posted its quarterly net income at $62.7 million, or $1.17 per share, down from $78.1 million, or $1.46 per share, in the year-ago period. To read the full news, click here.
- Merck (NYSE: MRK) today announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). To read the full news, click here.
- Aetna (NYSE: AET) reported a downbeat profit for the third quarter. Aetna's quarterly net income came in at $517 million, or $1.38 per share, versus a year-ago profit of $499 million, or $1.47 per share. To read the full news, click here.
- AngioDynamics (NASDAQ: ANGO) today announced EU CE Mark approval for its AngioVac venous drainage cannula and cardiopulmonary bypass circuit for use during extracorporeal bypass for up to six hours. To read the full news, click here.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.